Business & Investment

ITC: Need to be more consistent with ITC and global health care trends

Promoting health care is also one of the key areas of ITC’s corporate social responsibility program.

Synopsis

ITC shares rose 1.5% on Thursday thanks to a company that conducted clinical trials to develop Covid-19 prophylactic nasal drops. Once all the required approvals have been obtained, we will sell nasal drops under the Savlon brand. Investors supported the move, even though it was still in its infancy for the company.

ET Intelligence Group: ITC shares rose 1.5% on Thursday thanks to a company that conducted clinical trials to develop Covid-19 prophylactic nasal drops. Once all the required approvals have been obtained, we will sell nasal drops under the Savlon brand. Investors supported the move, even though it was still in its infancy for the company. For business conglomerates facing the heat of tobacco sales

  • Gift article
  • font size
  • save
  • printing
  • comment

Sign in to read the full article

You have this prime story as a free gift

Are you already a member?

ET Prime Special Offer

Get 20% off flat

About ET Prime Membership

Receive an offer

why ??

  • Exclusive Economic Times Stories, Editorials, Expert Opinions Over 20 sectors

  • Stock analysis. Market research.Industry trends Over 4000 shares

  • Clean experience
    Minimal advertising

  • Comments and Engage With the ET Prime Community

  • Exclusive invitation to Virtual event with industry leaders

  • Reliable team Journalists and analysts Who can best filter the signal from noise

ITC: Need to be more consistent with ITC and global health care trends

https://economictimes.indiatimes.com/markets/stocks/news/itcs-alignment-with-healthcares-a-global-trend-it-needs-to-deepen/articleshow/87920530.cms ITC: Need to be more consistent with ITC and global health care trends

Back to top button